Clinical Trial Update: Efficacy and Safety of YD0743 Treatment for Sepsis-Associated ARDS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of YD0743 for sepsis-associated ARDS is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome
• Sepsis

Drugs mentioned

• YD0743

Snippet

Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | Conditions: Sepsis | Phase 2 | Status: RECRUITING